This company listing is no longer active
Resumen de acción OVN
Oventus Medical Limited, a medical device company, develops and commercializes oral appliances for the treatment of obstructive sleep apnoea (OSA) and snoring in Australia, Canada, and the United States.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Recompensas
Análisis de riesgos
+ 2 riesgos adicionales
Competidores de Oventus Medical Limited
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.02 |
| 52 Week High | AU$0.15 |
| 52 Week Low | AU$0.017 |
| Beta | 0.89 |
| 1 Month Change | 0% |
| 3 Month Change | -9.09% |
| 1 Year Change | -80.00% |
| 3 Year Change | -96.49% |
| 5 Year Change | -94.03% |
| Change since IPO | -97.14% |
Noticias y actualizaciones recientes
Recent updates
We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Oventus Medical Limited's (ASX:OVN) CEO For Now
Nov 11
Is Oventus Medical (ASX:OVN) In A Good Position To Invest In Growth?
May 09Is Oventus Medical (ASX:OVN) In A Good Position To Invest In Growth?
Jan 24
Loss-Making Oventus Medical Limited (ASX:OVN) Expected To Breakeven In The Medium-Term
Nov 30Rentabilidad de los accionistas
| OVN | AU Medical Equipment | Mercado AU | |
|---|---|---|---|
| 7D | 0% | -0.2% | 0.7% |
| 1Y | -80.0% | 15.5% | 6.3% |
Rentabilidad vs. Industria: OVN underperformed the Australian Medical Equipment industry which returned -21.1% over the past year.
Rentabilidad vs. Mercado: OVN underperformed the Australian Market which returned -9.8% over the past year.
Volatilidad de los precios
| OVN volatility | |
|---|---|
| OVN Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 10.0% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in AU Market | 17.4% |
| 10% least volatile stocks in AU Market | 3.5% |
Precio estable de las acciones: OVN has not had significant price volatility in the past 3 months.
Volatilidad a lo largo del tiempo: Insufficient data to determine OVN's volatility change over the past year.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 2015 | n/a | John Cox | o2vent.com |
Resumen de fundamentos de Oventus Medical Limited
| Estadísticas fundamentales de OVN | |
|---|---|
| Capitalización bursátil | AU$4.83m |
| Beneficios(TTM) | -AU$10.29m |
| Ingresos (TTM) | AU$1.09m |
4.4x
Ratio precio-ventas (PS)-0.5x
Ratio precio-beneficio (PE)¿Está OVN sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de OVN | |
|---|---|
| Ingresos | AU$1.09m |
| Coste de los ingresos | AU$654.09k |
| Beneficio bruto | AU$439.45k |
| Otros gastos | AU$10.73m |
| Beneficios | -AU$10.29m |
Últimos beneficios comunicados
Dec 31, 2021
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | -0.043 |
| Margen bruto | 40.18% |
| Margen de beneficio neto | -941.33% |
| Ratio deuda/patrimonio | 0% |
¿Cómo se ha desempeñado OVN a largo plazo?
Ver rendimiento histórico y comparativa